Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AbbVie
Pharma
AbbVie's Skyrizi continues booming growth trajectory
As Humira continues its sales free fall, newer Skyrizi proved a worthy successor over the first quarter with nearly matching sales.
Zoey Becker
Apr 26, 2024 12:06pm
Head-to-head, it's AbbVie's Rinvoq over Regeneron's Dupixent
Apr 26, 2024 7:39am
AbbVie starts open casting call for next faces of Botox ads
Apr 24, 2024 8:40am
AbbVie tops, J&J drops as physicians rank immunology players
Apr 19, 2024 7:30am
AbbVie's Rinvoq passes muster in yet another autoimmune disease
Apr 18, 2024 9:57am
Medincell, AbbVie set out to create new long-acting injectables
Apr 17, 2024 2:49pm